Cresta Advisors’s Johnson & Johnson JNJ Stock Holding History

Cresta Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-124	Closed	-$25.7K	–	112
2025 Q4	$25.7K	Buy	+124	New	+$24.5K	0.01%	94
2023 Q1	–	Sell	-2,979	Closed	-$526K	–	40
2022 Q4	$526K	Sell	2,979 -1,131	-28%	-$195K	0.46%	22
2022 Q3	$671K	Buy	+4,110	New	+$695K	0.83%	17

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cresta Advisors's JNJ Position: Q1 2026 in Review

Cresta Advisors sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 124 shares — an estimated $25.7K sold.

Cresta Advisors first reported a position in JNJ in Q3 2022 and held it in 3 quarters. The position peaked at $671K in Q3 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Cresta Advisors reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Cresta Advisors sold 124 Johnson & Johnson shares in Q1 2026, an estimated $25.7K.
Cresta Advisors first reported a position in Johnson & Johnson in Q3 2022 and held it in 3 quarters.
Cresta Advisors's Johnson & Johnson position peaked at $671K in Q3 2022.
4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cresta Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.